Immucell vs Idexx Laboratories: revenue, profit, margins and growth compared
Immucell brought in $27.6M of revenue in fiscal 2025, Idexx Laboratories $4.3B in fiscal 2025. Revenue changed by +4.3% at Immucell and +10.4% at Idexx Laboratories on the year before, so Idexx Laboratories grew faster. Immucell kept -3.8% of its revenue as net profit, Idexx Laboratories 24.6%. Free cash flow was $1.2M at Immucell and $1.1B at Idexx Laboratories.
Fiscal years as each company reports them; the two may end in different months.
Questions about Immucell and Idexx Laboratories
Which is bigger by revenue, Immucell or Idexx Laboratories?
Idexx Laboratories is bigger by revenue: $4.3B in fiscal 2025, against $27.6M for Immucell in fiscal 2025.
Which keeps more of its revenue as profit, Immucell or Idexx Laboratories?
Immucell had a net margin of -3.8% in fiscal 2025; Idexx Laboratories had 24.6% in fiscal 2025.
Which grew revenue faster, Immucell or Idexx Laboratories?
In their latest fiscal years revenue changed by +4.3% at Immucell and +10.4% at Idexx Laboratories.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.